Management of Femoral Artery Access Complications

Prevention and Management

The American College of Cardiology recommends radial artery access as the preferred approach for PCI procedures to reduce vascular complications, but when femoral access is necessary, a systematic approach to complication prevention and management is essential 1, 2
High-risk patients should be identified before the procedure, including those with advanced age, female sex, low body weight, renal insufficiency, anemia, peripheral arterial disease, and use of glycoprotein IIb/IIIa inhibitors 3, 4, 5
Ultrasound-guided access should be considered to reduce complications, particularly in high-risk patients 5

Vascular access site bleeding is the most common complication after PCI via femoral access, with an overall incidence of 2-6% 3, 4, 5
Risk factors for vascular access site bleeding include female sex, advanced age, renal insufficiency, anemia, use of GP IIb/IIIa inhibitors, and low-molecular-weight heparin within 48 hours of PCI 6, 7
Retroperitoneal bleeding should be suspected when a patient develops unexplained hypotension, bradycardia or tachycardia, high vascular puncture site, and decreased hemoglobin 6, 8

Conservative management is usually sufficient for hemodynamically stable patients with retroperitoneal bleeding 6, 8
For unstable patients or expanding hematomas, early vascular surgical or interventional consultation should be obtained 6, 8
The American College of Cardiology recommends careful management of anticoagulation and antiplatelet therapy to reduce complications 2
Direct oral anticoagulants are preferred over vitamin K antagonists when feasible for patients requiring anticoagulation post-PCI 2

Anticoagulation therapy should typically be resumed within 24 hours after PCI, depending on hemostasis status 2
Blood glucose levels should be maintained below 180 mg/dL while avoiding hypoglycemia 6, 8
Transfusion should be avoided unless hemoglobin level is <8 mg/dL in the absence of ongoing ischemia 6, 8